SCYNEXIS, Inc. (SCYX) vs Talphera, Inc. (TLPH)
SCYNEXIS, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $60.7M against $45.0M — 1.4× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −73.1%. Talphera, Inc. has the higher net margin (0.00% vs −49.7%) and the higher return on invested capital (0.00% vs −110.7%). Across the 16 metrics below, SCYNEXIS, Inc. leads on 9 and Talphera, Inc. on 7.
Valuation
Profitability
| Metric | SCYX | TLPH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 53.94% |
| Operating margin | (109.90%) | 0.00% | 0.00% |
| Net margin | (49.74%) | 0.00% | 0.00% |
| Free cash flow margin | (64.67%) | 0.00% | 0.00% |
| Return on equity | (18.38%) | (143.36%) | (0.40%) |
| Return on assets | (15.09%) | (69.60%) | (3.32%) |
| Return on invested capital | (110.72%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack